
BMT Physician @MSKCC | @WeillCornell Graduate School | NK Cell Immunotherapy | Passionate about nature and family
Manhattan, NY
Joined November 2021
- Tweets229
- Following432
- Followers486
- Likes1.3K
Brian Shaffer retweeted
🚨 BIG NEWS in Cell Therapy! 🚨
New donor selection guidelines—developed with @CIBMTR & partners—are now published in the Journal for Transplantation and Cellular Therapy! 🧬
They reflect the latest in GVHD, expanded donor options & search strategies.
🔗 go.nmdp.org/44CTu8N
Brian Shaffer retweeted
Featured today by @MSKLibrary: Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703 dx.doi.org/10.1200/JCO.24.00…
#BMTCTN1703 #PatientReportedOutcomes #QualityOfLife #TransplantResearch
@sghmd @GvHD_Meade @DrMonzrAlMalki #JuanWu #CarrieLKitko #RanReshef @AndrewRezvan @BrianShafferMD @MelhemSolh @YaoJanny @LRunaas #HanyElmariah #KarilynTLarkin #NajlaElJurdi @MGooptu #AlisonLoren @AricHallMD #AminMAlousi #OmerJamy #WilliamClark @KeanMD @AmiBhattMD #MiguelAngelPerales #KristyApplegate
@YEfebera #EricLeifer #RichardJJones @bmtdata #DeborahMattila @wlsaber @MediHumdani #MichaelJMartens
Brian Shaffer retweeted
Just out in @ASTCT: Updated allogeneic stem cell donor selection guidelines from the CIBMTR/NMDP. Kudos to @mskcancercenter's @BrianShafferMD and team! #stemcelltransplant #Cancer sciencedirect.com/science/ar…
Brian Shaffer retweeted
NEW study results just published in @JCO_ASCO: Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis Following Mismatched Unrelated Donor PBSC Transplantation. Read more: ascopubs.org/doi/10.1200/JCO…
Brian Shaffer retweeted
Amazing to have been part of this endeavour! #donorsforeveryone
@DrStevenDevine @BrianShafferMD @amjimenezmd @DrMonzrAlMalki @JeffAuletta @spellman_s
.@MGooptu, @DanaFarber, and collaborators confirm a new approach to stem cell transplant donor matching that that expands access to safe hematopoietic stem cell transplants across all racial and ethnic backgrounds.
bit.ly/4fDXiKS
Brian Shaffer retweeted
Here we go! @BrianShafferMD leading us through the morning session addressing controversies re: #PTCy. Dose? Alternatives? Toxicities? @ASTCT #ToxicitiesConference24
Brian Shaffer retweeted
New CIBMTR Research – the first analysis from @BMTCTN 1702! Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: An Interventional Trial. Read more, here:
medrxiv.org/content/10.1101/…
Brian Shaffer retweeted
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors ➡️ brnw.ch/21wLw9Y @BrianShafferMD @DrStevenDevine #hemonc
Brian Shaffer retweeted
I am once again asking you to consider prescribing olanzapine for patients experiencing chemotherapy-induced nausea/vomiting
* it's an effective antiemetic
* it can enable better sleep (but less daytime somnolence at 2.5mg vs. 10mg)
* it can boost mood
thelancet.com/journals/lanon…
Brian Shaffer retweeted
Congrats to @BrianShafferMD @amjimenezmd @JeffAuletta @GvHD_Meade and the entire study team for this important study showing we have further leveled the playing field in alloSCT including MMUD using PTCy.
Congrats also to @CIBMTR and @nmdp_org.
The future is very bright!
Just published in @JCO_ASCO: Post-Transplant Cyclophosphamide–Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors | @nmdp_org ascopubs.org/doi/10.1200/JCO…
Brian Shaffer retweeted
Duh! Easiest yes of the day. 100% committed to the lifesaving mission of @nmdp_org
Brian Shaffer retweeted
Closer towards a donor for everyone! Fantastic working with this team
@BrianShafferMD @amjimenezmd @DrStevenDevine @JeffAuletta @DrMonzrAlMalki @spellman_s
Excited to share our latest work out today in @JCO_ASCO
A collaborative work with many colleagues
@DrStevenDevine
@MGooptu
@amjimenezmd
@DrMonzrAlMalki
@JeffAuletta
@martinmaiers
and many others.
ascopubs.org/doi/10.1200/JCO…
Brian Shaffer retweeted
One week to go! Don't miss out on the excitement at this year's #MSKlymphomaCME @MSKCancerCenter. Dive into cutting-edge topics, engage w/ top experts, network w/ peers; plus, an exclusive session tailored for nurses & APPs. Register: bit.ly/Lymphoma2024
@gilles_salles
Brian Shaffer retweeted
My latest story is about how a very old and very cheap drug has been quietly revolutionizing bone-marrow transplants.
(1/3)
Brian Shaffer retweeted
Not our night. Plenty to be proud about this season.
#GoDukes
Brian Shaffer retweeted
For me, Google is the #1 AI company in the world and kickstarted the whole revolution with "Attention is all you need", BERT, T5 and many more.
I'm ecstatic to be able to collaborate with @sundarpichai @ThomasOrTK @JeffDean @fchollet and the whole Google org to democratize AI thanks to open-source AI and open science! Let's go!
Brian Shaffer retweeted
Introducing NMDP! Our new name reflects decades of life-saving work as the most diverse blood stem cell donor registry and as leading research and health care partners. Together, let’s imagine a world where EVERY patient can receive life-saving cell therapy.
Brian Shaffer retweeted
Is an IPSS-R of 4.5 the right cutoff for transplant eligibility? 🤔
The window has almost closed for the public comment on the CMS proposal for allogeneic HCT coverage for #MDS.
Please review, and if you feel modifications should be made, comment 👇
cms.gov/medicare-coverage-da…
Brian Shaffer retweeted
🧵 The historic NYT v. @OpenAI lawsuit filed this morning, as broken down by me, an IP and AI lawyer, general counsel, and longtime tech person and enthusiast.
Tl;dr - It's the best case yet alleging that generative AI is copyright infringement. Thread. 👇



























